TD
Tapati Das
About Tapati Das
Data last updated:
Tapati Das is a Director at Jac Olivol Products Private Limited (since 2024), Director at Hahnemann's Jac Olivol Group Of Products Private Limited (since 2024) and Director at Hahnemann Laboratory Drugs & Cosmetics Private Limited (since 2024), and holds 10 more current directorships. The companies operate in Healthcare, FMCG and Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹131 Cr; the largest is Jac Olivol Products Private Limited at ₹113 Cr (FY 2025). Earlier, Tapati Das was a Designated Partner at Hahnemann Laboratory Drugs & Cosmetics Llp (from 2010) and Director at Hahnemann Laboratory Drugs & Cosmetics Private Limited (from 2004) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Jac Olivol Products Private Limited U21003WB2019PTC234801 | Director | 01 Mar 2024 | 2019 | ₹113 Cr (FY 2025) | Active |
| Hahnemann's Jac Olivol Group Of Products Private Limited U24232WB2021PTC245072 | Director | 01 Mar 2024 | 2021 | ₹14.83 Cr (FY 2024) | Active |
| Hahnemann Laboratory Drugs & Cosmetics Private Limited U24230WB2022PTC257077 | Director | 01 Mar 2024 | 2022 | ₹3.14 Cr (FY 2025) | Active |
| Hanelab Pvt Ltd U51397WB1977PTC031168 | Director | 24 Mar 2006 | 1977 | ₹1 Lakh (FY 2017) | Active |
| Das Global Business Ventures Private Limited U74999WB2022PTC258876 | Director | 01 Mar 2024 | 2022 | Active | |
| Jac Olivol Herbal Products Private Limited U68200WB2018PTC224404 | Director | 01 Mar 2024 | 2018 | Active | |
| Hahnemann Laboratory Private Limited U24290WB2020PTC236541 | Director | 01 Mar 2024 | 2020 | Active | |
| Hl Homoeopathic & Biochemic Llp AAK-6180 | Designated Partner | 18 Sep 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 20 Jul 2010 | 2010 | Converted To Cmp And Dissolved | ||
| Hahnemann Laboratory Drugs & Cosmetics Private Limited U24239WB2004PTC098567 | Director | 19 May 2004 | 2004 | Converted To Llp | |
| Designated Partner | 26 Apr 2013 | 2013 | Converted To Cmp And Dissolved |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Tapati Das
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pradipta Biswas | 03587674 | Jac Olivol Products Private Limited , Das Global Business Ventures Private Limited and 1 more | Director |
| Rajarshi Das | 02914373 | Jac Olivol Products Private Limited , Hahnemann's Jac Olivol Group Of Products Private Limited and 11 more | Director |
| Ritesh Das | 07940709 | Jac Olivol Products Private Limited , Hahnemann's Jac Olivol Group Of Products Private Limited and 11 more | Director |
| Indranil Chatterjee | 08399866 | Hanelab Pvt Ltd | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tapati Das
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tapati Das
Tapati Das currently holds 13 directorships: Jac Olivol Products Private Limited (Director, since 01 Mar 2024, revenue ₹113 Cr (FY 2025)); Hahnemann's Jac Olivol Group Of Products Private Limited (Director, since 01 Mar 2024, revenue ₹14.83 Cr (FY 2024)); Hahnemann Laboratory Drugs & Cosmetics Private Limited (Director, since 01 Mar 2024, revenue ₹3.14 Cr (FY 2025)); Hanelab Pvt Ltd (Director, since 24 Mar 2006, revenue ₹1 Lakh (FY 2017)); Das Global Business Ventures Private Limited (Director, since 01 Mar 2024); and 8 more.
Tapati Das was first appointed on 24 Jun 1998 as Director at Aar - Dee International Private Limited. The most recent appointment on record is 01 Mar 2024 at Hahnemann Laboratory Private Limited.
The 4 current companies of Tapati Das that report revenue have a combined latest revenue of ₹131 Cr: Jac Olivol Products Private Limited ₹113 Cr (FY 2025); Hahnemann's Jac Olivol Group Of Products Private Limited ₹14.83 Cr (FY 2024); Hahnemann Laboratory Drugs & Cosmetics Private Limited ₹3.14 Cr (FY 2025); Hanelab Pvt Ltd ₹1 Lakh (FY 2017).
Tapati Das held 3 earlier board appointments: Hahnemann Laboratory Drugs & Cosmetics Llp (Designated Partner, from 20 Jul 2010); Hahnemann Laboratory Drugs & Cosmetics Private Limited (Director, from 19 May 2004); Hahnemann's Jac Olivol Group Of Products Llp (Designated Partner, from 26 Apr 2013).
The current boards of Tapati Das's companies include Pradipta Biswas (Jac Olivol Products Private Limited), Rajarshi Das (Jac Olivol Products Private Limited), Ritesh Das (Jac Olivol Products Private Limited), Indranil Chatterjee (Hanelab Pvt Ltd).